Free provider profile
KYLE SMITH, DO
BAY SHORE, NY
Find similar providers: Family Medicine in BAY SHORE, NY
Practice contact details
Source: CMS NPPES · published practice information
Practice phone
631-666-1956
Fax
631-666-1957
Practice address
340 HOWELLS RD, BAY SHORE, NY, 11706
- Registry updated
- 2021-06-15
- NPI issued
- 2018-04-11
- RepVector retrieved
- 11/22/2026
A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.
Specialties & registration
CMS NPPES taxonomy classifications · not verification of certification or services offered
Family Medicine
207Q00000X
PrimaryStudent in an Organized Health Care Education/Training Program
390200000X
2 registered practice locations · A registry listing does not establish active practice, referral relationships or insurance participation.
Need more providers like KYLE SMITH?
See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.
Rep intel
What KYLE SMITH prescribes and who else does
Top Medicare Part D drugs by claims (public CMS data):
- Eliquis
- Januvia
- Ozempic
- Trelegy Ellipta
- Trulicity
See all family medicine physicians in NY who bill Medicare →
Your next referral list starts here
Provider + market indicator
A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.
Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
13,654
Medicare patients
1,156
Part D drug cost
$1,104,696
Brand-name share
14.8%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Eliquis (Apixaban) | 502 | $173,281 |
| Santyl (Collagenase Clostridium Hist.) | 24 | $73,454 |
| Ozempic (Semaglutide) | 52 | $59,281 |
| Invega Sustenna (Paliperidone Palmitate) | 12 | $44,092 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | 43 | $32,675 |
| Trulicity (Dulaglutide) | 35 | $30,892 |
| Januvia (Sitagliptin Phosphate) | 60 | $26,580 |
| Mounjaro (Tirzepatide) | 21 | $23,683 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Latest Medicare Part B billing
CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.
Loading the latest published CMS billing file…
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
Checking Open Payments…
Industry payments across NY — which companies pay providers there.
Open Payments page for this provider
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.
